Corvus Pharmaceuticals (CRVS) Return on Capital Employed Growth (3y) (2019 - 2026)
Corvus Pharmaceuticals (CRVS) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | 4,853.00 |
| 10 | Corvus Pharmaceuticals | 1.18 Bn | 944.94 Mn | - | 2,735.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,735.00 |
| Sep 30, 2025 | -291.00 |
| Jun 30, 2025 | -1,570.00 |
| Mar 31, 2025 | -1,753.00 |
| Sep 30, 2024 | -12,374.00 |
| Jun 30, 2024 | -1,618.00 |
| Mar 31, 2024 | -1,366.00 |
| Dec 31, 2023 | 1,885.00 |
| Sep 30, 2023 | 4,527.00 |
| Jun 30, 2023 | 2,146.00 |
| Mar 31, 2023 | 1,659.00 |
| Jun 30, 2022 | 1,480.00 |
| Mar 31, 2022 | 801.00 |
| Dec 31, 2021 | 565.00 |
| Sep 30, 2021 | -21.00 |
| Jun 30, 2021 | -486.00 |
| Mar 31, 2021 | -84.00 |
| Dec 31, 2020 | -1,250.00 |
| Sep 30, 2020 | -3,889.00 |
| Jun 30, 2020 | -3,429.00 |